Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-22-004984

Head of Pharm Ops and Tech gave up 92 shares (to pay taxes)

  • Head of Pharm Ops and Tech acquired 263 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Murphy Nicole · Head of Pharm Ops and Tech

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-02-12 Exercise or conversion : show line 1 in the form +263 1,488.89 D
2022-02-12 Shares withheld for taxes : show line 2 in the form −92 $214.59 $19,742 1,396.89 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-02-12 Exercise or conversion : show line 3 in the form Restricted Stock Unit −263 1,245 D
2022-02-12 Other disposition : show line 4 in the form Restricted Stock Unit −489 756 D
Loading xslF345X03/form4.xml…